SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance

  • Cancer Res. 2017 Dec 15;77(24):6914-6926. doi: 10.1158/0008-5472.CAN-17-2105.
Arturo Orlacchio  1 Michela Ranieri  1 Martina Brave  1 Valeria Antico Arciuch  1 Toni Forde  1 Daniela De Martino  1 Karen E Anderson  2 Phillip Hawkins  2 Antonio Di Cristofano  3
Affiliations
  • 1. Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York.
  • 2. Inositide Laboratory, Babraham Institute, Babraham, Cambridge, United Kingdom.
  • 3. Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York. [email protected].
Abstract

Activation of the PI3K-AKT signaling cascade is a common critical event during malignant transformation. In this study, we used thyroid gland epithelial cells and a series of genetically engineered mouse strains as model systems to demonstrate that, although necessary, Akt activation is not sufficient for PI3K-driven transformation. Instead, transformation requires the activity of the PDK1-regulated AGC family of protein kinases. In particular, SGK1 was found to be essential for proliferation and survival of thyroid Cancer cells harboring PI3K-activating mutations. Notably, cotargeting SGK1 and Akt resulted in significantly higher growth suppression than inhibiting either PI3K or Akt alone. Overall, these findings underscore the clinical relevance of AKT-independent pathways in tumors driven by genetic lesions targeting the PI3K cascade. Cancer Res; 77(24); 6914-26. ©2017 AACR.